Specific tolerance induction and organ transplantation.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Leukemia and Lymphoma

• Publication date

  1998-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10428199809057593PMID 9720723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microchimerism and rejection in clinical transplantation.

  1997cited by this paper
• Clonal deletion is one mechanism responsible for tolerance in mixed hematopoietic chimeras.

  1997cited by this paper
• Stem cell transfusion as a new method for the induction of tolerance in organ transplantation.

  1997cited by this paper
• Specific tolerance induction and transplantation: a single-day protocol.

  1997cited by this paper
• The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

  1997cited by this paper
• Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients.

  1997cited by this paper
• Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

  1997cited by this paper
• Mechanism for cotolerance in nonlethally conditioned mixed chimeras: negative selection of the Vbeta T-cell receptor repertoire by both host and donor bone marrow-derived cells.

  1996cited by this paper
• MHC class II tolerant T cells undergo apoptosis upon re-exposure to tolerogen in vivo.

  1996cited by this paper
• Semi‐allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness

  1996cited by this paper
• Gene therapy and transplantation--a brief review.

  1996cited by this paper
• Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice

  1996cited by this paper
• A substantial level of mixed chimerism is required for the induction of permanent transplantation tolerance.

  1996cited by this paper
• Induction of tolerance by intrathymic inoculation of alloantigen.

  1996cited by this paper
• Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism.

  1995cited by this paper
• Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.

  1995cited by this paper
• Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys

  1995cited by this paper
• A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.

  1995cited by this paper
• Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10.

  1995cited by this paper
• Donor-type microchimerism associated with graft rejection eight years after liver transplantation.

  1994cited by this paper
• Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft tolerance.

  1994cited by this paper
• Peripheral microchimerism in long-term cadaveric-kidney allograft recipients.

  1994cited by this paper
• Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation.

  1994cited by this paper
• Patterns of donor-type microchimerism after heart transplantation.

  1994cited by this paper
• Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.

  1994cited by this paper
• Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.

  1994cited by this paper
• Mechanisms of transplantation tolerance.

  1994cited by this paper
• "Infectious" transplantation tolerance

  1993cited by this paper
• Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides.

  1993cited by this paper
• CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION

  1993cited by this paper
• Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene.

  1993cited by this paper
• T cell mediated immunosuppression.

  1993cited by this paper
• Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: host T-cell suppression, growth factors, and space.

  1992cited by this paper
• Cell migration, chimerism, and graft acceptance.

  1992cited by this paper
• DOWN‐REGULATION OF THE IMMUNE RESPONSE TO HISTOCOMPATIBILITY ANTIGENS AND PREVENTION OF SENSITIZATION BY SKIN ALLOGRAFTS BY ORALLY ADMINISTERED ALLOANTIGEN1

  1992cited by this paper
• Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression

  1992cited by this paper
• Systemic chimerism in human female recipients of male livers.

  1992cited by this paper
• Tolerance in the mouse to major histocompatibility complex‐mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8

  1992cited by this paper
• Pretransplantation blood transfusion revisited.

  1991cited by this paper
• Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation?

  1991cited by this paper
• Induction of donor-specific unresponsiveness by intrathymic islet transplantation.

  1990cited by this paper
• Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation

  1990cited by this paper
• Induction of tolerance in peripheral T cells with monoclonal antibodies

  1990cited by this paper
• The influence of allogeneic cells on the human T and B cell repertoire.

  1990cited by this paper
• Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.

  1989cited by this paper
• Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

  1989cited by this paper
• A nondeletional mechanism of thymic self tolerance.

  1989cited by this paper
• Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.

  1989cited by this paper
• Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide

  1989cited by this paper
• Induction of classical transplantation tolerance in the adult

  1989cited by this paper
• Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.

  1988cited by this paper
• In vivo administration of anti-CD3 prevents malignant progressor tumor growth.

  1988cited by this paper
• Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes

  1988cited by this paper
• Effect of blood transfusions on subsequent kidney transplants.

  1973cited by this paper
• ‘Actively Acquired Tolerance’ of Foreign Cells

  1953cited by this paper

• Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells.

  2014cites this paper
• Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers

  2004cites this paper
• Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers

  2003cites this paper
• CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.

  2003cites this paper
• Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.

  2003cites this paper
• Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion?

  2003cites this paper
• Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models.

  2002cites this paper
• Transplantation tolerance induced by mixed chimerism.

  2001cites this paper